Please provide your email address to receive an email when new articles are posted on . Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb), an eye drop that prevents tear evaporation, can ...
A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...
A detailed assessment of the current market landscape of novel ocular drug delivery devices, with respect to type of drug delivery device (implants, inserts and punctal plugs), current status of ...
VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio There is general agreement in ...
CHICAGO — A novel sustained-release travoprost punctum plug (TTP) is able to achieve therapeutic drug delivery levels over 30 days. The TTP may be an alternative to topical drops, particularly in ...
BEDFORD, Mass., Oct. 12 Ocular Therapeutix, Inc. announced today the completion of a successful Proof of Principle clinical study with their novel sustained drug delivery moxifloxacin punctum plug.
VANCOUVER, British Columbia, Aug. 29, 2011 (GLOBE NEWSWIRE) -- QLT Inc. /quotes/zigman/13615/quotes/nls/qlti QLTI +1.81% /quotes/zigman/13629 CA:QLT +1.99% today ...
At this time, I’d like to turn the conference over to Karen Peterson, Investor Relations Specialist. Please go ahead. Karen Peterson – Investor Relations Specialist Good morning everyone and welcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback